Latest News
Equillium, Inc.
- Equillium, Inc. Estimates – LS:A2N7B3
- Equillium clears Australian hurdle for first human trial of ulcerative colitis AhR modulator
- Equillium cleared to start Phase I trial of oral AhR modulator EQ504
- Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
- Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504
- Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
- Equillium Announces Poster Presentations at the 7th International AHR Conference
- Equillium (EQ) Stock Analysis Report | Financials & Insights
Headlines from the last 30 days, linking to the original publishers. See all market news →